FISH Analysis
of Microorga­nisms
more information
more information
Detection, Identification and Localization of Pathogens
more information
Testing of Antimicrobial Implant Surfaces
more information
Visualization of Biofilms on Single Cell Level
more information
Standardized Efficacy Measurement of Antimicrobial Substances
more information

MoKi Analytics GmbH
Your partner for FISH analysis of microorganisms

MoKi Analytics offers innovative services and products for the molecular biological detection of microorganisms.

Our focus is the microscopic analysis of samples with molecular probes (Fluorescence in situ Hybridzation – FISH). Our services encompass the detection of microbial communities, so called biofilms, and analysis of in vitro or tissue samples.

We combine the microscopic detection of microorganisms with molecular biological methods like PCR, real-time PCR, Sanger sequencing or Next-Generation Sequencing (NGS) for microbiome analysis.

Research and Funding

MoKi Analytics was established with the financial support of the program EXIST by the Federal Ministry for Economic Affairs and Energy, as well as the European Union (Europäischer Sozialfonds für Deutschland).

The European Union and the European Regional Development Fund support MoKi Analytics research since 2019 for an innovative efficacy measurement of antimicrobial surfaces and substances by FISH.

Since 2020, MoKi Analytics is leading a KMU Innovative joint research project ‘PROCEED’, supported by the Federal Ministry of Education and Research. Aim of the project is to personalize prevention and diagnostics of dental implant infections (peri-implantitis) by molecular imaging.

Also since 2020, MoKi is proud partner of the EU ITN-project (Innovative Training Network) ‘GROWTH’ ( and in the EU Twinning-project ‘CEMBO’ (

Since 2021, we are very happy to lead the research consortium ‘TEAM’, and to be partner in the research consortium ‘FIELD’, both supported by the Federal Ministry of Education and Research. ‘TEAM’ aims to improve diagnostics and therapy of infective endocarditis by FISH, whereas ‘FIELD’ aims to establish FISH in the field for improved diagnosis of tuberculosis.